Almstead Neil Gregory's Form 4 filing
PTC Therapeutics, Inc. (PTCT) · filed Apr 3, 2026
- Accession no.
- 0001578850-26-000012
- Filed
- Apr 3, 2026
- Trade date
- Apr 1, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 3 non-derivative transactions. Open-market sales total $3.59M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Almstead Neil GregoryCIK 0001578850 | Officer (CHIEF TECHNICAL OPS OFFICER) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 1, 2026 | Common Stock | SSaleDisposed | −39,393 | $68.89F2 | −$2,713,783.77 | 72,747 | Direct | |
| Apr 1, 2026 | Common Stock | SSaleDisposed | −12,530 | $69.50F3 | −$870,835 | 60,217 | Direct | |
| Apr 1, 2026 | Common Stock | SSaleDisposed | −80 | $70.30 | −$5,624 | 60,137 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $68.26 to $69.26 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F3
This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $69.26 to $70.13 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.